Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Invitrogen Corporation (NasdaqNM:IVGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
1600 Faraday Avenue
Carlsbad, CA 92008
Phone: (760) 603-7200
Fax: (760) 602-6500
Employees (last reported count): 2,981
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Subsidiaries
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 14%
·Over the last 6 months:
 · 11 insider sells; 924.0K shares
  (11.2% of insider shares)
·Institutional: 93% (108% of float)
(476 institutions)
·Net Inst. Buying: 3.80M shares (+7.23%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Invitrogen Corporation develops, manufactures and markets more than 10,000 products for the life sciences markets. The Company's products are principally research tools in reagent and kit form, biochemicals, sera, media, and other products and services, which the Company sells to corporate, academic and government entities. The Company focuses its business on two principal segments, Molecular Biology Products and Cell Culture Products.
More from Market Guide: Expanded Business Description

Financial Summary
IVGN develops, manufactures and markets research tools in kit form that improve gene cloning, expression and analysis techniques, and also provides research services to corporate, academic and government entities. For the six months ended 6/30/01, revenues totaled $320 million, up from $55 million. Net loss totaled $74.7 million vs. an income of $3 million. Results reflect additional revenue from the Life Technologies merger, offset by acquisition-related expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Lyle Turner, 47
Chairman, Pres, CEO
$333K--  
James Glynn, 54
CFO, Exec. VP, Director
317K$11M
Lewis Shuster, 45
Pres of Genomics
256K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:IVGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$38.50 
Recent Price$68.03 
52-Week High
on 3-Nov-2000
$87.438
Beta1.12 
Daily Volume (3-month avg)1.05M
Daily Volume (10-day avg)640.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+8.7%
52-Week Change
relative to S&P500
+45.9%
Share-Related Items
Market Capitalization$3.59B
Shares Outstanding52.7M
Float45.4M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$32.74 
Earnings (ttm)-$2.69 
Earnings (mrq)-$0.67 
Sales (ttm)$11.45 
Cash (mrq)$9.57 
Valuation Ratios
Price/Book (mrq)2.08 
Price/EarningsN/A 
Price/Sales (ttm)5.94 
Income Statements
Sales (ttm)$511.2M
EBITDA (ttm)$69.4M
Income available to common (ttm)-$131.9M
Profitability
Profit Margin (ttm)-25.6%
Operating Margin (ttm)-29.5%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-6.54%
Return on Equity (ttm)-11.77%
Financial Strength
Current Ratio (mrq)5.72 
Debt/Equity (mrq)0.11 
Total Cash (mrq)$503.9M
Short Interest
As of 8-Aug-2001
Shares Short2.58M
Percent of Float5.7%
Shares Short
(Prior Month)
2.56M
Short Ratio2.26 
Daily Volume1.14M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.